Beyond the Petri dish: Testing tomorrow's drugs in human blood
The COVID vaccine is perhaps the first thing many people think of when they hear about mRNA-based drugs. Small packages of genetic material are sent into the body, prompting cells to produce useful proteins in the fight against the virus. But the list of diseases that can potenti
The COVID vaccine is perhaps the first thing many people think of when they hear about mRNA-based drugs. Small packages of genetic material are sent into the body, prompting cells to produce useful proteins in the fight against the virus. But the list of diseases that can potenti This story matters for Science & Discovery readers tracking inventors. Reported by phys.org. Read the full original at the source link below.
Originally reported by phys.org. InventorsNews.com curates and briefs the science & discovery stories that matter. Our editorial policy →
Get the daily inventors signal